Ascendis Pharma A/S (ASND)

Ascendis Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	7,715	7,262	6,965	7,242	8,792	6,642
Market Cap Growth	42.36%	4.27%	-3.82%	-17.63%	32.38%	152.21%
Enterprise Value	8,090	7,534	6,723	6,586	8,027	6,011
PE Ratio	-	-13.57	-11.23	-16.61	-17.21	-27.11
PS Ratio	21.57	24.50	127.93	819.32	1036.86	441.94
PB Ratio	-33.70	-44.86	24.86	7.21	8.60	9.90
P/FCF Ratio	-18.96	-13.91	-13.08	-14.42	-25.03	-32.64
P/OCF Ratio	-19.02	-13.98	-13.21	-15.26	-26.55	-33.60
EV/Sales Ratio	22.62	25.42	123.50	745.12	946.71	399.96
EV/EBITDA Ratio	-23.61	-16.49	-12.41	-15.89	-20.01	-25.43
EV/EBIT Ratio	-22.41	-15.77	-11.98	-15.25	-19.46	-24.65
EV/FCF Ratio	-19.78	-14.43	-12.62	-13.12	-22.85	-29.54
Debt / Equity Ratio	-2.81	-4.42	1.93	0.12	0.11	0.06
Debt / EBITDA Ratio	-1.89	-1.57	-1.00	-0.29	-0.28	-0.17
Debt / FCF Ratio	-1.58	-1.37	-1.02	-0.24	-0.32	-0.20
Quick Ratio	0.49	0.62	4.45	7.04	13.78	12.61
Current Ratio	0.83	0.95	5.39	8.03	14.02	12.74
Asset Turnover	0.40	0.31	0.04	0.01	0.01	0.02
Interest Coverage	-3.13	-9.76	-10.44	-97.17	-4.19	-177.75
Return on Equity (ROE)	511.20%	-14914.70%	-116.90%	-45.60%	-59.50%	-32.90%
Return on Assets (ROA)	-60.30%	-55.20%	-46.00%	-37.40%	-52.20%	-29.70%
Return on Capital (ROIC)	-83.79%	-91.37%	-72.80%	-45.70%	-35.52%	-35.78%
Earnings Yield	-7.07%	-7.37%	-8.91%	-6.02%	-5.81%	-3.69%
FCF Yield	-5.90%	-7.19%	-7.65%	-6.93%	-4.00%	-3.06%
Buyback Yield / Dilution	-1.41%	-0.38%	-2.37%	-8.21%	-8.84%	-13.20%
Total Shareholder Return	-1.41%	-0.38%	-2.37%	-8.21%	-8.84%	-13.20%

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).